About OSEM
OSEM is a Healthcare company based in Marina Del Rey (United States) founded in 2023. An automated platform utilizing microfluidics for biopharmaceutical processes. It operates on a B2B model. Its focus areas include Biotechnology, Biopharmaceuticals and Microfluidics Platforms. Its competitors include Flashpoint Therapeutics and DNA Nanobots; 1 of its 2 listed competitors has raised funding.
Company details
OSEM, established in 2023, excels in providing healthcare solutions, advancing biotech innovations, biopharmaceuticals, and microfluidics platforms. An automated platform utilizing microfluidics for biopharmaceutical processes. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Marina Del Rey, United States
- SectorsHealthcare
- Email••••••••
- Website osem.bio
Competitors of OSEM
OSEM has 2 listed competitors in our database, 1 of them funded. They include Flashpoint Therapeutics and DNA Nanobots.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| flashpoint.bio | 2022 | Palo Alto, United States | $10M | Flashpoint Therapeutics is developing nanotherapeutic candidates that can deliver precise RNA, DNA, and peptide payloads to specific cells at the right time. | ||
| dnananobots.com | 2021 | Powell, United States | Targeted chemotherapy, vaccines, and gene therapy are delivered via nanotechnology. |
Detailed competitors of OSEM
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as OSEM (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about OSEM
OSEM was founded in 2023.
OSEM is headquartered in Marina Del Rey, United States. It is registered at Marina Del Rey, California, United States.
OSEM, established in 2023, excels in providing healthcare solutions, advancing biotech innovations, biopharmaceuticals, and microfluidics platforms. An automated platform utilizing microfluidics for biopharmaceutical processes. Committed to advancing standards, it focuses on innovation, efficiency, and delivering value to clients worldwide. It continues to evolve, meeting industry challenges with strategic approaches.
OSEM's top competitors include Flashpoint Therapeutics and DNA Nanobots.